Home › Salivary Gland Cancer › Kansas City
Salivary Gland Cancer clinical trials in Kansas City, MO
3 studies for Salivary Gland Cancer are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RecruitingPhase 2
- University of Kansas Cancer Center, Westwood · 5 mi away
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
RecruitingPhase 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- and 1 more
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- and 1 more
About Salivary Gland Cancer
Salivary glands empty saliva into your mouth. Salivary gland cancer is a rare type of head and neck cancer. Learn about the associated symptoms.
More about Salivary Gland Cancer on MedlinePlus
Salivary Gland Cancer trials in other cities
- Boston, MA5 studies
- Nashville, TN5 studies
- New York City, NY4 studies
- Houston, TX4 studies
- Queens, NY3 studies
- Dallas, TX3 studies
- Highlands Ranch, CO3 studies
- Philadelphia, PA3 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer29 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer18 studies
- Colorectal Cancer16 studies
- Prostate Cancer16 studies
- Metastatic Cancer14 studies
- Acute Myeloid Leukemia14 studies
- Ovarian Cancer12 studies
- Type 2 Diabetes11 studies
- Cardiovascular Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.